Correction and maintenance study of subcutaneous injections of R744 to predialysis patients (phase III, comparative study in comparison with epoetin beta)

Trial Profile

Correction and maintenance study of subcutaneous injections of R744 to predialysis patients (phase III, comparative study in comparison with epoetin beta)

Completed
Phase of Trial: Phase III

Latest Information Update: 27 May 2016

At a glance

  • Drugs Epoetin beta; Methoxy polyethylene glycol-epoetin beta
  • Indications Anaemia
  • Focus Therapeutic Use
  • Sponsors Chugai Pharmaceutical
  • Most Recent Events

    • 06 Jan 2009 Status changed from active, no longer recruiting to completed.
    • 09 Jun 2008 The expected completion date for this trial is now 1 Jan 2008 as reported by ClinicalTrials.gov.
    • 29 Jan 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top